198 related articles for article (PubMed ID: 34211033)
21. Circadian rhythmicity in substance use disorder male patients with and without comorbid depression under ambulatory and therapeutic community treatment.
Antúnez JM; Capella MD; Navarro JF; Adan A
Chronobiol Int; 2016; 33(10):1410-1421. PubMed ID: 27611843
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis.
Hunt GE; Malhi GS; Lai HMX; Cleary M
J Affect Disord; 2020 Apr; 266():288-304. PubMed ID: 32056890
[TBL] [Abstract][Full Text] [Related]
23. Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine.
Becerril-Villanueva E; Pérez-Sánchez G; Alvarez-Herrera S; Girón-Pérez MI; Arreola R; Cruz-Fuentes C; Palacios L; de la Peña FR; Pavón L
Mediators Inflamm; 2019; 2019():9130868. PubMed ID: 31827384
[TBL] [Abstract][Full Text] [Related]
24. Comorbid depression, antisocial personality, and substance dependence: Relationship with delay discounting.
Moody L; Franck C; Bickel WK
Drug Alcohol Depend; 2016 Mar; 160():190-6. PubMed ID: 26846198
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study.
Torres-Galván S; Flores-López M; Ochoa E; Requena-Ocaña N; Araos P; Herrera-Imbroda J; Muga R; Serrano A; Rodríguez de Fonseca F; Pavón-Morón FJ; Haro G; García-Marchena N
Neuropsychobiology; 2024; 83(2):73-88. PubMed ID: 38768577
[TBL] [Abstract][Full Text] [Related]
26. Associations Between Lifetime Panic Attacks, Posttraumatic Stress Disorder, and Substance Use Disorders in a Nationally Representative Sample.
Blakey SM; Campbell SB; Simpson TL
J Dual Diagn; 2022; 18(1):21-32. PubMed ID: 34965200
[No Abstract] [Full Text] [Related]
27. Independent versus substance-induced major depressive disorders in first-admission patients with substance use disorders: an exploratory study.
Langås AM; Malt UF; Opjordsmoen S
J Affect Disord; 2013 Jan; 144(3):279-83. PubMed ID: 23158758
[TBL] [Abstract][Full Text] [Related]
28. Cross-sectional volumetric analysis of brain atrophy in alcohol dependence: effects of drinking history and comorbid substance use disorder.
Bjork JM; Grant SJ; Hommer DW
Am J Psychiatry; 2003 Nov; 160(11):2038-45. PubMed ID: 14594753
[TBL] [Abstract][Full Text] [Related]
29. Personality Profile and Clinical Correlates of Patients With Substance Use Disorder With and Without Comorbid Depression Under Treatment.
Marquez-Arrico JE; Río-Martínez L; Navarro JF; Prat G; Adan A
Front Psychiatry; 2018; 9():764. PubMed ID: 30687142
[No Abstract] [Full Text] [Related]
30. High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population.
Roberts W; Moore KE; Pittman BP; Fillmore MT; McKee SA
J Stud Alcohol Drugs; 2019 Jan; 80(1):114-119. PubMed ID: 30807283
[TBL] [Abstract][Full Text] [Related]
31. Patterns of co-occurring addictions, posttraumatic stress disorder, and major depressive disorder in detoxification treatment seekers: Implications for improving detoxification treatment outcomes.
Anderson RE; Hruska B; Boros AP; Richardson CJ; Delahanty DL
J Subst Abuse Treat; 2018 Mar; 86():45-51. PubMed ID: 29415850
[TBL] [Abstract][Full Text] [Related]
32. Correlates of major depressive disorder with and without comorbid alcohol use disorder nationally in the veterans health administration.
Yoon G; Petrakis IL; Rosenheck RA
Am J Addict; 2015 Aug; 24(5):419-26. PubMed ID: 25950244
[TBL] [Abstract][Full Text] [Related]
33. Depressed patients with co-occurring alcohol use disorders: a unique patient population.
Sher L; Stanley BH; Harkavy-Friedman JM; Carballo JJ; Arendt M; Brent DA; Sperling D; Lizardi D; Mann JJ; Oquendo MA
J Clin Psychiatry; 2008 Jun; 69(6):907-15. PubMed ID: 18422397
[TBL] [Abstract][Full Text] [Related]
34. Onset of alcohol or substance use disorders following treatment for adolescent depression.
Curry J; Silva S; Rohde P; Ginsburg G; Kennard B; Kratochvil C; Simons A; Kirchner J; May D; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
J Consult Clin Psychol; 2012 Apr; 80(2):299-312. PubMed ID: 22250853
[TBL] [Abstract][Full Text] [Related]
35. Coping strategies related to treatment in substance use disorder patients with and without comorbid depression.
Adan A; Antúnez JM; Navarro JF
Psychiatry Res; 2017 May; 251():325-332. PubMed ID: 28237911
[TBL] [Abstract][Full Text] [Related]
36. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
Clark RE; Xie H; Brunette MF
J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
[TBL] [Abstract][Full Text] [Related]
37. Sex differences in circulating inflammatory mediators as a function of substance use disorder.
May AC; Burrows K; Figueroa-Hall LK; Kirlic N; White EJ; Smith R; Ekhtiari H; Paulus MP; Savitz J; Stewart JL;
Drug Alcohol Depend; 2021 Apr; 221():108610. PubMed ID: 33631550
[TBL] [Abstract][Full Text] [Related]
38. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
39. Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder.
Hashemzadeh I; Marquez-Arrico JE; Hashemzadeh K; Navarro JF; Adan A
Front Psychiatry; 2021; 12():750500. PubMed ID: 34777054
[No Abstract] [Full Text] [Related]
40. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.
Schieber LZ; Dunphy C; Schieber RA; Lopes-Cardozo B; Moonesinghe R; Guy GP
JAMA Psychiatry; 2023 Apr; 80(4):331-341. PubMed ID: 36790774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
